Detalles de la búsqueda
1.
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.
Int J Cancer
; 150(4): 626-635, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558665
2.
Comparison of Clinical Characteristics and Outcomes of Hospitalized Patients Infected with the D614G Strain or Alpha Variant of COVID-19 in Taiwan: A Multi-Center Cohort Study.
Int J Med Sci
; 19(13): 1912-1919, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36438919
3.
A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.
BMC Cancer
; 21(1): 309, 2021 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761908
4.
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Thorac Cancer
; 15(7): 529-537, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279515
5.
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Ther Adv Med Oncol
; 16: 17588359231222604, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249338
6.
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
Vaccines (Basel)
; 12(5)2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793725
7.
Effects of dexamethasone use on viral clearance among patients with COVID-19: a multicenter cohort study.
Int J Infect Dis
; 128: 257-264, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642207
8.
Clinical and laboratory predictors for disease progression in patients with COVID-19: A multi-center cohort study.
Biomed J
; 46(1): 100-109, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36414180
9.
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.
Target Oncol
; 18(2): 195-207, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805452
10.
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.
Front Oncol
; 13: 1249106, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854677
11.
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.
Sci Rep
; 13(1): 20323, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989860
12.
Plasma thrombomodulin levels are associated with acute kidney injury in patients with acute heart failure.
Ann Med
; 54(1): 3169-3176, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36354140
13.
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.
Ther Adv Med Oncol
; 14: 17588359221113278, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35898964
14.
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.
Cancers (Basel)
; 14(2)2022 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053480
15.
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis.
Sci Rep
; 12(1): 4398, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292755
16.
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.
Oncol Ther
; 9(2): 489-503, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33990928
17.
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
Ther Adv Med Oncol
; 13: 17588359211035710, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34377157
18.
Concomitant infection with COVID-19 and Mycoplasma pneumoniae.
Biomed J
; 43(5): 458-461, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891590
19.
The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma.
Biomedicines
; 8(2)2020 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32092879
20.
The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study.
Pharmaceuticals (Basel)
; 13(11)2020 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33113888